Bayer Aktiengesellschaft Bayer Aktiengesellschaft

Bayer Aktiengesellschaft

BAYN

株式のランク #490
Bayer Aktiengesellschaft operates as a life science company in Europe, the... Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
株価
$50.31
最終同期: 2026-10-21
時価総額
$49.43B
変化(1日)
-2.45%
変化(1年)
57.43%
国
DE
取引 Bayer Aktiengesellschaft (BAYN)

カテゴリー

Healthcare
Bayer Aktiengesellschaft(BAYN)のP/B比率
2026 時点のP/B比率 TTM: 0
Bayer Aktiengesellschaft の最新の財務報告および株価によると、現在のP/B比率(TTM)は 0 です。2026 年末時点でのP/B比率は 0 でした。
Bayer Aktiengesellschaft の P/B 比率の履歴(2026 ~ 2026)
各年末時点のP/B比率
年 P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
31.9092 -
US
7.3138 -
US
-84.6033 -
US
8.6873 -
US
8.4776 -
CH